These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11346373)

  • 1. Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy.
    Fedi M; Reutens D; Dubeau F; Andermann E; D'Agostino D; Andermann F
    Arch Neurol; 2001 May; 58(5):781-6. PubMed ID: 11346373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo.
    Koskiniemi M; Van Vleymen B; Hakamies L; Lamusuo S; Taalas J
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):344-8. PubMed ID: 9527146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of piracetam in cortical myoclonus.
    Brown P; Steiger MJ; Thompson PD; Rothwell JC; Day BL; Salama M; Waegemans T; Marsden CD
    Mov Disord; 1993; 8(1):63-8. PubMed ID: 8419809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
    Frucht SJ; Louis ED; Chuang C; Fahn S
    Neurology; 2001 Sep; 57(6):1112-4. PubMed ID: 11571347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abolition of photoparoxysmal response in progressive myoclonus epilepsy.
    Paulus W; Ried S; Stodieck SR; Schmidt D
    Eur Neurol; 1991; 31(6):388-90. PubMed ID: 1756763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
    Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P
    Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.
    Crest C; Dupont S; Leguern E; Adam C; Baulac M
    Neurology; 2004 Feb; 62(4):640-3. PubMed ID: 14981187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piracetam in the treatment of cortical myoclonus.
    Genton P; Guerrini R; Remy C
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():49-53. PubMed ID: 10338109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pharmacological profile of piracetam (Myocalm), a drug for myoclonus].
    Tajima K; Nanri M
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):209-14. PubMed ID: 11084917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical challenge of progressive myoclonus epilepsy.
    Tate E
    Nurse Pract; 1993 May; 18(5):25-8. PubMed ID: 8355898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Khani YA; Andermann F; Andermann E
    Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimyoclonic effect of levetiracetam.
    Genton P; Gélisse P
    Epileptic Disord; 2000 Dec; 2(4):209-12. PubMed ID: 11174151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimyoclonic action of piracetam.
    Obeso JA; Artieda J; Luquin MR; Vaamonde J; Martínez Lage JM
    Clin Neuropharmacol; 1986; 9(1):58-64. PubMed ID: 3103912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic effect of levetiracetam on epileptic negative myoclonus.
    Gelisse P; Crespel A; Genton P; Baldy-Moulinier M
    Acta Neurol Scand; 2003 Apr; 107(4):302-3. PubMed ID: 12675706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
    Malykh AG; Sadaie MR
    Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus.
    Pranzatelli MR; Tate ED; Galvan I; Wheeler A
    Clin Neuropharmacol; 2001; 24(6):352-7. PubMed ID: 11801811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.